Title: Clinical and Economic Case for Pre-op Skin Prepping
1(No Transcript)
2Postoperative SSIs
- Magnitude of Problem
- Despite advances in infection control practices,
SSIs remain a substantial cause of morbidity and
mortality among hospitalized patients. This may
partially be explained by the emergence of
antimicrobial-resistant pathogens and the
increased numbers of surgical patients who are
elderly and/or have a wide variety of chronic,
debilitating, or immunocompromising underlying
diseases.
Mangram AJ, et al., Guideline for prevention of
surgical site infection, 1999. Centers for
Disease Control and Prevention, Hospital
Infection Control Practices Advisory Committee,
Atlanta GA
3Postoperative SSIs
- Magnitude of Problem
- Approximately 60 million surgical procedures
performed per year in the U.S.1,2 - 2.6 to 5 of surgical procedures result in
surgical site infections (SSIs) 3,4 - At least 1.5 million SSIs per year in the U.S.5
- 1. DeFrances CJ, Hall MJ, Podgornik MN, 2003
National hospital discharge survey. CDC, National
Center for Health Statistics, Advance Data from
Vital and Health Statistics. No. 3598 July
200514. - 2. Hall MJ, Lawrence L, Ambulatory surgery in the
United States, 1996. CDC, National Center for
Health Statistics, Advance Data from Vital and
Health Statistics. No. 30012 Aug 19987. - 3. Mangram AJ, et al., Guideline for prevention
of surgical site infection, 1999. Centers for
Disease Control and Prevention, Hospital
Infection Control Practices Advisory Committee,
Atlanta GA. - 4. Institute for Healthcare Improvement (IHI),
Topics patient safety surgical site infections
case for improvement. (accessed 16 Jan 2006 at
http//www.ihi.org). - 5. Figure calculated by multiplying SSI rate from
ref. 3 by surgical procedure numbers from ref.
1 and 2.
4Surgical Site Infections
- The leading hospital-acquired infection for
surgicalpatients (38)1 - The third most common hospital-acquiredinfection
overall 1 - Patients who develop are twice as likely to die
and 60 more likely to spend time in the ICU 2 - Increase hospital length of stay by 7 to 10 days
1 - Account for more than 25,000 increase
inhospital costs 3 - One of the two most expensive infectionsto
healthcare 3
1. Mangram AJ, et al., Guideline for prevention
of surgical site infection, 1999. Centers for
Disease Control and Prevention, Hospital
Infection Control Practices Advisory Committee,
Atlanta GA. 2. Kirkland KB, et al., Infect
Control Hosp Epidemiol. Nov 199920(11)722-4. 3.
Stone PW, et al., Am J Infect Control. Nov
200533(9)501-9
5Goal Address a Known Risk Factor for SSIs
- Reduce themicroorganismson the patients skin.
- We should initiate acomprehensive approachfor
skin antisepsis.
6Current Practice
- Our current practice
- We have a protocol?
- The protocol is aligned with CDC guidelines for
preventing SSIs? - Compliance to protocol is?
- Hospital / surgeon compliance level?
- Patient compliance level?
7Where we want to be
- Establish multidisciplinary SSI prevention team
- Increased awareness
- Standardized pre-op prep protocol aligned with
CDC guidelines for preventing SSIs - High compliance to protocol
- Hospital / surgeon compliance gt90
- Patient compliance gt80
8Solution
- Pre-op skin prepping with CHG
- CHG is persistent, active for up to 6 hours
- Literature suggests that repeat applications
maximize antimicrobial effect - Rapid bactericidal action
- The only pre-op skin prep agent that the CDC
recognizes as having excellent activity against
gram-positive bacteria (i.e., MRSA) as well as
excellent residual activity
9Solution
- Pre-op skin prepping with Sage 2 CHG
- Only FDA-Approved cloth delivery of CHG
- Unique 2 CHG formulation Fast-acting and
broad spectrum Persistent Free of alcohol
and harsh detergents - Unique one-step applicator cloth Delivers a
uniform dose of CHG No drips, runs or
pooling Large cloth allows easy prepping of
body contours
10Implementation
11Awareness
Posters
12How Sage 2 CHG Works
13Thank Youfor your time!